These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25575935)

  • 21. Don't use antipsychotics routinely to treat agitation and aggression in people with dementia.
    Corbett A; Burns A; Ballard C
    BMJ; 2014 Nov; 349():g6420. PubMed ID: 25368388
    [No Abstract]   [Full Text] [Related]  

  • 22. Risperidone for Psychosis-Induced Aggression or Agitation.
    Scruth E
    Issues Ment Health Nurs; 2019 Nov; 40(11):988-989. PubMed ID: 31381459
    [No Abstract]   [Full Text] [Related]  

  • 23. Discontinuation of risperidone in Alzheimer's disease.
    Ling SM; Bonner AF; McMullen TL
    N Engl J Med; 2013 Jan; 368(2):187. PubMed ID: 23301740
    [No Abstract]   [Full Text] [Related]  

  • 24. Discontinuation of risperidone in Alzheimer's disease.
    Power GA
    N Engl J Med; 2013 Jan; 368(2):186-7. PubMed ID: 23301739
    [No Abstract]   [Full Text] [Related]  

  • 25. Discontinuation of risperidone in Alzheimer's disease.
    Gnjidic D; Hilmer SN
    N Engl J Med; 2013 Jan; 368(2):186. PubMed ID: 23301738
    [No Abstract]   [Full Text] [Related]  

  • 26. Discontinuation of risperidone in Alzheimer's disease.
    Devanand DP; Schultz SK; Sultzer DL
    N Engl J Med; 2013 Jan; 368(2):187-8. PubMed ID: 23301737
    [No Abstract]   [Full Text] [Related]  

  • 27. Galantamine added to antipsychotic treatment in chronic schizophrenia: cognitive improvement?
    Norén U; Björner A; Sonesson O; Eriksson L
    Schizophr Res; 2006 Jul; 85(1-3):302-4. PubMed ID: 16675200
    [No Abstract]   [Full Text] [Related]  

  • 28. [Longterm treatment with Risperidone in Alzheimer's disease? No justification for more "drug deaths" in nursing homes!].
    Förstl H
    Dtsch Med Wochenschr; 2013 Jan; 138(1-2):16. PubMed ID: 23250689
    [No Abstract]   [Full Text] [Related]  

  • 29. Antipsychotics for agitation in dementia.
    Ton J; Ramji J; Allan GM
    Can Fam Physician; 2018 May; 64(5):369. PubMed ID: 29760258
    [No Abstract]   [Full Text] [Related]  

  • 30. Dementia.
    Warner J; Butler R; Arya P
    Clin Evid; 2004 Jun; (11):1250-77. PubMed ID: 15652059
    [No Abstract]   [Full Text] [Related]  

  • 31. Liquid risperidone in the treatment of psychotic agitation.
    Tsai C; Puzantian T
    CNS Drugs; 2002; 16(11):777; author reply 778. PubMed ID: 12383033
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of dementia.
    Overshott R; Burns A
    J Neurol Neurosurg Psychiatry; 2005 Dec; 76 Suppl 5(Suppl 5):v53-9. PubMed ID: 16291922
    [No Abstract]   [Full Text] [Related]  

  • 33. A pilot, randomized, open-label trial assessing safety and pharmakokinetic parameters of co-administration of rivastigmine with risperidone in dementia patients with behavioral disturbances.
    Weiser M; Rotmensch HH; Korczyn AD; Hartman R; Cicin-Sain A; Anand R;
    Int J Geriatr Psychiatry; 2002 Apr; 17(4):343-6. PubMed ID: 11994888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid.
    Bloniecki V; Aarsland D; Blennow K; Cummings J; Falahati F; Winblad B; Freund-Levi Y
    J Alzheimers Dis; 2017; 57(2):387-393. PubMed ID: 28269767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH; Greenspan AJ; Choi SK
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):654-60. PubMed ID: 16821257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical antipsychotic agents ineffective for AD.
    Duke Med Health News; 2007 Jan; 13(1):8. PubMed ID: 17299888
    [No Abstract]   [Full Text] [Related]  

  • 38. Current attitudes regarding treatment of agitation and psychosis in dementia.
    Serby MJ; Roane DM; Lantz MS; Cohen AJ; Turok A; Perlis TE
    Am J Geriatr Psychiatry; 2009 Feb; 17(2):174. PubMed ID: 19155750
    [No Abstract]   [Full Text] [Related]  

  • 39. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
    Kurlan R; Cummings J; Raman R; Thal L;
    Neurology; 2007 Apr; 68(17):1356-63. PubMed ID: 17452579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action.
    Raskind MA; Wang LY
    Int Psychogeriatr; 2014 Jun; 26(6):879-83. PubMed ID: 24703502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.